Business
AREV CLOSES SECOND TRAUNCHE OF $450,000 Non Brokered Private Placement
AREV CLOSES SECOND TRAUNCHE OF $450,000 Non Brokered Private Placement.
About this update from Arev Life Sciences Global Corp.
[{"type":"text","content":"VANCOUVER, BC / April 17, 2020 / AREV BRANDS INTERNATIONAL LTD. (CSE: AREV) (OTC: AREVF) (“AREV Brands”) announces the Company has closed $225,0000 tranche (3,750,000 UNITS) of a non brokered Private Placement Unit Offering to raise a total of $450,000 announced March 24th. Each Unit is priced at $0.06 per unit and comprised of one common share (the “Shares”) of the Company and one common share purchase warrant (each whole one, the “Warrants”) and with each Warrant being exercisable at $0.08 per Warrant Share. Subject to adjustment in certain events, each whole Warrant entitles the holder thereof to purchase one additional common share (the “Warrant Shares”) of the Company at any time on or before 5:00 p.m. (Vancouver time) on the date that is 24 months from the date of issuance of the Warrants.The funds will be used to secure key pieces of equipment, general working capital, product development and distribution.For further information, contact Mike Withrow, [email protected] 778-929-6536.On behalf of the Board,Mike WithrowCEO & DirectorAbout AREV NanoTec Inc. AREV NanoTec Brands Inc. (“AREV”) produces and sells functional ingredients produced via its proprietary extraction systems. These premium ingredients and products are targeted for the natural health, medical, functional food, nutraceutical, sport nutrition markets. AREV’s model is to toll process extraction of targeted essential and functional oils and license its formulations to Licensed Producers in Canada. The company utilizes toll processors in foreign countries to encapsulate and package its formulations that can be sold in traditional distribution channels and online.NEITHER THE CANADIAN SECURITIES EXCHANGE NOR ITS REGULATIONS SERVICES PROVIDER HAVE REVIEWED OR ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.FORWARD LOOKING INFORMATIONNeither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in policies of the CSE) accepts responsibility for the adequacy or accuracy of this release. This news release may include forward-looking statements that are subject to risks and uncertainties. All statements within, other than statements of historical fact, are to be considered forward looking. Although the Company believes the expectations expressed in such forward looking statements are ba...